Product NDC: | 0115-1470 |
Proprietary Name: | Mometasone Furoate |
Non Proprietary Name: | Mometasone Furoate |
Active Ingredient(s): | 1 mg/g & nbsp; Mometasone Furoate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0115-1470 |
Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076591 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070418 |
Package NDC: | 0115-1470-46 |
Package Description: | 1 TUBE in 1 CARTON (0115-1470-46) > 45 g in 1 TUBE |
NDC Code | 0115-1470-46 |
Proprietary Name | Mometasone Furoate |
Package Description | 1 TUBE in 1 CARTON (0115-1470-46) > 45 g in 1 TUBE |
Product NDC | 0115-1470 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Mometasone Furoate |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20070418 |
Marketing Category Name | ANDA |
Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
Substance Name | MOMETASONE FUROATE |
Strength Number | 1 |
Strength Unit | mg/g |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA] |